Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Apr 12, 2025

‘First Published by Managing IP‘ By: Achuthan Sreekumar Achuthan Sreekumar of Anand and Anand draws on a recent High Court of Delhi ruling

Life and death matter? The protection of well-known personal names in India
Thought Leadership
Mar 27, 2025

‘First published on Lexology’ By: Safir Anand and Abhishek Paliwal India, one of the world’s fastest-growing economies, is on track to become a

Company Name vs. Trademark: Essential Insights for Establishing Your Business Brand in India
Thought Leadership
Mar 19, 2025

‘First published on Chambers and Partners’ By: Safir Anand and Twinky Rampal Law and Practice  1. Trade Mark and Copyright Law  1.1 Governing

Chambers Trademarks & Copyright 2025 | Law & Practice
Thought Leadership
Mar 19, 2025

‘First published on Chambers and Partners’ By: Safir Anand Introduction The landscape of intellectual property in India is undergoing a significant

Chambers Trademarks & Copyright 2025 | Trends and Developments